Affective reactivity to daily stressors and immune cell gene expression in the MIDUS study

By sjmartinez • October 6, 2023

Apsley AT, Lee SA, Bhat AC, Rush J, Almeida DM, Cole SW, Shalev I. Affective reactivity to daily stressors and immune cell gene expression in the MIDUS study. Brain Behav Immun. 2023 Oct 3:S0889-1591(23)00289-1. doi: 10.1016/j.bbi.2023.09.025. Epub ahead of print. PMID: 37797778.

Tags: Affective reactivity, Conserved transcriptional response to adversity (CTRA), Daily-diary methods, Hematology/Oncology, Inflammation, Publications, Stress

Related Posts

Results from a phase 1b study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small cell lung cancer (NSCLC) after progression on prior osimertinib

Horinouchi H, Cho BC, Camidge DR, Goto K, Tomasini P, Li Y, Vasilopoulos A, Brunsdon P, Hoffman D, Shi W, Bolotin E, Blot V, Goldman[...]

ZNFX1 functions as a master regulator of epigenetically induced pathogen mimicry and inflammasome signaling in cancer

Stojanovic L, Abbotts R, Tripathi K, Coon CM, Rajendran S, Abbasi Farid E, Hostetter G, Guarnieri JW, Wallace DC, Liu S, Wan J, Calendo G,[...]

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study

Kudo M, Ren Z, Guo Y, Han G, Lin H, Zheng J, Ogasawara S, Kim JH, Zhao H, Li C, Madoff DC, Ghobrial RM, Kawaoka[...]